X Bioscience Public Company Limited
X Bioscience Public Company Limited, together with its subsidiaries, sells food and beverages in Thailand. It engages in the food and beverages investment and restaurant businesses. The company also manufactures and sells biological products; and generates and transmits electric power. Its brands include Kagonoya, Le Boeuf, and Bake Cheese Tart. The company was formerly known as Wow Factor Public… Read more
X Bioscience Public Company Limited (XBIO) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2024: -0.028x
Based on the latest financial reports, X Bioscience Public Company Limited (XBIO) has a cash flow conversion efficiency ratio of -0.028x as of September 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (฿-7.52 Million) by net assets (฿264.02 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
X Bioscience Public Company Limited - Cash Flow Conversion Efficiency Trend (2020–2023)
This chart illustrates how X Bioscience Public Company Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
X Bioscience Public Company Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of X Bioscience Public Company Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Grupo Famsa S.A.B. de C.V
MX:GFAMSAA
|
0.002x |
|
BIJOU BRIGITTE
MU:BIJ
|
N/A |
|
COSW
BATS:COSW
|
N/A |
|
Puget Technologies Inc
PINK:PUGE
|
0.284x |
|
LifeX 2030 Income Bucket ETF
BATS:BCKT
|
N/A |
|
Intergama
TA:INTR
|
0.054x |
|
BERKELEY GRP - Dusseldorf Stock Exchang
DU:42BA
|
N/A |
|
Hiru Corporation
PINK:HIRU
|
-0.018x |
Annual Cash Flow Conversion Efficiency for X Bioscience Public Company Limited (2020–2023)
The table below shows the annual cash flow conversion efficiency of X Bioscience Public Company Limited from 2020 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | ฿182.81 Million | ฿-76.31 Million | -0.417x | +71.91% |
| 2022-12-31 | ฿102.54 Million | ฿-152.41 Million | -1.486x | -619.35% |
| 2021-12-31 | ฿673.41 Million | ฿-139.13 Million | -0.207x | -550.50% |
| 2020-12-31 | ฿948.11 Million | ฿-30.11 Million | -0.032x | -- |